Brazg R, Xu L, Dalla Man C, et al. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Diabetes Obes Metab. 2007;9:186-93.
Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome.
Endocr Rev. 2008;29:777-822.
Despres JP, Golay A, Sjostrom L, et al. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
N Engl J Med. 2005;353:2121-2134.
Diabetes mellitus type 2. EBSCO DynaMed website. Available at:
. Updated April 26, 2013. Accessed May 10, 2013.
Fibric acid derivatives. EBSCO DynaMed website. Available at:
. Updated March 4, 2013. Accessed May 10, 2013.
Freemark M. Pharmacotherapy of childhood obesity.
Diabetes Care. 2007;30:395-402.
How is metabolic syndrome treated? National Heart, Lung, and Blood Institute website. Available at:
. Updated November 3, 2011. Accessed May 10, 2013.
Hypertension. EBSCO DynaMed website. Available at:
. Updated March 22, 2013. Accessed May 10, 2013.
Hypertriglyceridemia. EBSCO DynaMed website. Available at:
. Updated January 17, 2013. Accessed May 10, 2013.
Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity.
Ann Intern Med. 2005;142:532-546.
Medication. American Diabetes Association website. Available at:
. Accessed May 10, 2013.
Metabolic syndrome. EBSCO DynaMed website. Available at:
. Updated March 29, 2013. Accessed May 10, 2013.
Orchar TJ, Temprosa M, Goldberg R, et al. The effect of diet and exercise or metformin on the metabolic syndrome: The diabetes prevention program randomized trial.
Annals of Internal Medicine. 2005;142:611-619.
Rosenstock J, Fitchet M. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
Int J Clin Pract Suppl. 2008;159:15-23.
Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
Expert Opin Pharmacother. 2008; 9:1237-1248.
Steinberger J, Daniels SR, Eckel RH, et al. AHA Scienfic Statement: Progress and Challenges in Metabolic Syndrome in children and Adolescents.
Types of blood pressure medications. American Heart Association website. Available at:
. Updated August 14, 2012. Accessed May 10, 2013.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.